Energy Full Spectrum

$41.75$252.75

  • .5oz (15ml)
  • 1oz (30ml)
  • 2oz (60ml)
  • Regular Strength
  • 2X Double Strength
Clear
    Reset options
SKU N/A Categories ,
If you have any questions, click the blue button in the lower right corner to chat or send us a message

$41.75$252.75 or from $33.40$202.20 / month

Federal Farm Bill compliant with less than 0.3% THC.

1000mg – 2000mg of Full Spectrum CBD + other Terpenes and 900mg of Yohimbe per fluid ounce, in Organic MCT Coconut Oil. Full spectrum, sometimes called “whole plant,” means the full plant extract is included. Federal Farm Bill compliant, contains less than 0.3% THC. See more at CBD Info and COAs below. Tastes like hemp.

Yohimbe is an African evergreen tree whose bark promotes the release of nitric oxide. It only takes a little bit to feel a difference, and some people can be sensitive to it, so please start with a small amount and adjust as you find out what works best for you.

  • .5oz (15ml)
  • 1oz (30ml)
  • 2oz (60ml)
  • Regular Strength
  • 2X Double Strength
Clear
    Reset options
SKU N/A Categories ,

Description

1000mg – 2000mg of Full Spectrum CBD + other Terpenes and 900mg of Yohimbe per fluid ounce, in Organic MCT Coconut Oil. Full spectrum, sometimes called “whole plant,” means the full plant extract is included. Federal Farm Bill compliant, contains less than 0.3% THC. See more at CBD Info and COAs below. Tastes like hemp.

Yohimbe is an African evergreen tree whose bark promotes the release of nitric oxide. It only takes a little bit to feel a difference, and some people can be sensitive to it, so please start with a small amount and adjust as you find out what works best for you.

Ingredients

1. 1000mg – 2000mg Full Spectrum CBD + other Terpenes per ounce (see full list of cannabinoids and terpenes below)
2. Organic Medium-Chain Triglycerides (MCT) Coconut Oil
3. 900mg of Yohimbe extract

Additional information

Weight N/A
Dimensions N/A
Size

.5oz (15ml), 1oz (30ml), 2oz (60ml)

Fs Strength

Regular Strength, 2X Double Strength

NCBI Studies and Information

We strongly encourage you to do additional research to determine which CBD products are best for you. Due to FDA regulations, we cannot share all of the benefits of cannabidiol, but we can link to reputable, third-party resources that can.  The links below will open up sites outside of hellobluecbd.com in a new tab. If you have any questions, please don’t hesitate to click the blue bubble in the lower right corner to chat with us, or send a message through our contact page.

Anxiety Relief

Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1

Bergamaschi MM, Queiroz RH, Chagas MH, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011;36(6):1219-1226. doi:10.1038/npp.2011.6

Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. Front Immunol. 2018;9:2009. Published 2018 Sep 21. doi:10.3389/fimmu.2018.02009

Pain Relief

Ryz NR, Remillard DJ, Russo EB. Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. Cannabis Cannabinoid Res. 2017;2(1):210-216. Published 2017 Aug 1. doi:10.1089/can.2017.0028

Sports Performance

McCartney D, Benson MJ, Desbrow B, Irwin C, Suraev A, McGregor IS. Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research. Sports Med Open. 2020;6(1):27. Published 2020 Jul 6. doi:10.1186/s40798-020-00251-0

General Use in Therapy and Psychiatry

Calapai G, Mannucci C, Chinou I, et al. Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. Evid Based Complement Alternat Med. 2019;2019:2509129. Published 2019 Aug 29. doi:10.1155/2019/2509129

Elsaid S, Kloiber S, Le Foll B. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28. PMID: 31601406.

Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Cannabidiol (CBD) use in psychiatric disorders: A systematic review. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. PMID: 31412258.

Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiol Psychiatr Sci. 2018 Aug;27(4):327-335. doi: 10.1017/S2045796018000239. Epub 2018 May 23. PMID: 29789034; PMCID: PMC6998871.

Calapai G, Mannucci C, Chinou I, et al. Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry. Evid Based Complement Alternat Med. 2019;2019:2509129. Published 2019 Aug 29. doi:10.1155/2019/2509129

Reviews

There are no reviews yet.

Be the first to review “Energy Full Spectrum”

Your email address will not be published. Required fields are marked *